Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$210K Sell
597
-84
-12% -$29.9K 0.09% 143
2025
Q4
$223K Buy
+681
New +$216K 0.1% 133
2024
Q3
Sell
-2
Closed -$625 123
2024
Q2
$625 Buy
+2
New +$588 ﹤0.01% 364

Other funds holding AMGN

Chris Bulman's AMGN Position: Q1 2026 in Review

Chris Bulman reduced its Amgen (AMGN) stake by 12% in Q1 2026, selling an estimated $29.9K and leaving 597 shares worth $210K. The position accounts for 0.09% of the portfolio, ranked #143.

Chris Bulman first reported a position in AMGN in Q2 2024 and has held it in 3 quarters since. The position peaked at $223K in Q4 2025. 3,126 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Chris Bulman held 597 shares of Amgen worth $210K as of Q1 2026.
  • Chris Bulman sold 84 Amgen shares in Q1 2026, an estimated $29.9K.
  • Amgen made up 0.09% of Chris Bulman's portfolio in Q1 2026, its #143 holding.
  • Chris Bulman first reported a position in Amgen in Q2 2024 and has held it in 3 quarters since.
  • Chris Bulman's Amgen position peaked at $223K in Q4 2025.
  • 3,126 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Chris Bulman's 13F filing for Q1 2026, filed 13 Apr 2026.